Johnson & Johnson: Smoking Cessation trials
The registry lists 25 Smoking Cessation studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 5Phase 2 2Phase 3 2Phase 4 1No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit SmokingTerminatedNCT01296698Phase 3Results posted
- Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® MicrotabCompletedNCT01238640Not applicableResults posted
- Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.CompletedNCT01084707Not applicableResults posted
- Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement ProductCompletedNCT01084603Not applicableResults posted
- Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch TreatmentCompletedNCT00749463Phase 4Results posted
- Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine GumCompletedNCT01368016Not applicable
- "EASY EFFECTIVE SMOKELESS" With NICORETTE®CompletedNCT01323491
- Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCompletedNCT01321931Phase 1
- Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mgCompletedNCT01238627Not applicable
- Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement ProductsCompletedNCT01234896Not applicable
- Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.CompletedNCT01234792Not applicable
- Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCompletedNCT01228617Not applicable
- Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.CompletedNCT01227720Not applicable
- Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152749Not applicable
- Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152736Not applicable
- Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® GumCompletedNCT01152723Not applicable
- Bioequivalence Between Nicotine Replacement Products and Nicorette® GumCompletedNCT01113424Not applicable
- Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ LozengeCompletedNCT01075659Phase 2
- Cumulative Skin Irritation Potential of a New 25 mg Nicotine PatchCompletedNCT00967174Phase 1
- Skin Sensitization Potential of a New Nicotine PatchCompletedNCT00967070Phase 1
- Photoirritation and Photoallergic Potential of a New Nicotine PatchCompletedNCT00966901Phase 1
- Cumulative Skin Irritation Potential of a New 15 mg Nicotine PatchCompletedNCT00965913Phase 1
- Efficacy and Safety Following Use of a Novel Nicotine Replacement TherapyCompletedNCT00882375Not applicable
- Smoking Reduction or Cessation With Nicotine Replacement TherapyCompletedNCT00840242Phase 3
- Pilot Study of a New Nicotine Replacement TherapyCompletedNCT00764439Phase 2